Back to available technologies

Novel Use of a1 AR Subtype-Selective Drugs in Patients with Acute Myocardial Infarction

The present invention relates to the use of α1aAR-selective and/or α1a/α1d-selective antagonists in a method of preventing restenosis after myocardial infarction and re-perfusion. The invention further relates to a method of identifying agents suitable for us in such a method.

Duke File (IDF) Number

T-001690

Inventor(s)

  • Schwinn, Debra

For more information please contact

College

School of Medicine (SOM)

Interested in this Technology?

Submit your interest below.